Asia-Pacific Congress on Gastrointestinal Malignancies in conjunction with the 8th TCOG Annual Meeting

Dec. 4-5, 2004

Session I: Symposium on Colorectal Cancer (I)

Topic Speaker
Advances in the First Line Treatment of Advanced Colorectal Cancer Richard M
Targeted Therapies for the Treatment of Advanced Colorectal Cancer Edward Chu
Targeted Anticancer Therapies: New Paradigms for Drug Development Chris H. M. Takimoto
Molecular Profiling of Colorectal Cancer Robert B. Diasio
rTS Signaling Pathway: New Pre-clinical Strategies for Drug Development in Colorectal Cancer Bruce J. Dolnick

Session II: Symposium on Gastric Cancer

Topic Speaker
The Systemic Therapy of Gastric Cancer: Current and Future Trends Philip Agop Philip
Current Status and New Advances of Chemotherapy in Gastric Cancer Tetsuo Taguchi
Current Status of Adjuvant Chemotherapy in Gastric and Colorectal Cancer Masashi Fujii
Role of Nodal Dissection for Gastric Cancer: Taipei Randomized Trial Chew-Wun Wu

Session III: Symposium on Colorectal Cancer (II)

Topic Speaker
Adjuvant Therapy in Colon Cancer Richard M. Goldberg
New Approaches for the Treatment of Rectal Cancer Edward Chu
Novel Targeted Cancer Therapies; Clinical Development Programs at the National Cancer Institute John Joseph Wright

Session IV: Symposium on Hepatocellular Carcinoma

Topic Speaker
Chemotherapy for Hepatocellular Carcinoma: Reality and Challenge; and Development of Novel Therapy Weijing Sun
Effects of Lamivudine on Development of Hepatocellular Carcinoma in Advanced Chronic Hepatitis B Rong-Nan Chien
Adjuvant Interferon Alfa-2b Significantly Improves the Survival in Curatively Resected High-risk Hepatocellular Carcinoma – The Taiwan Cooperative Oncology Group (T1297) Study Li-Tzong Chen
Share Button

Comments are closed.